CClinicalTrials.gg
WithdrawnNCT06374680Updated Apr 22, 2024

C3 Laminectomy With Cervical Laminoplasty

An observational study in Neck Pain, sponsored by Seoul National University Hospital. Withdrawn at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-22.

Sponsored by Seoul National University Hospital · Observational

Why this study was withdrawn
This is because the same research has already been done.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
20 Years to 80 Years
Sex
All
01

Study summary

  1. Background In cervical stenosis, cervical laminoplasty from the third to sixth cervical vertebrae is widely used. However, the muscles attached to the C2, which play an important role in the movement of our neck, are frequently damaged during the C3 laminoplasty. In contrast, cervical spine surgery through the removal of the C3 is thought to give less damage to the muscles attached to the C2.
  2. Purpose The aim of this study was to compare the prospective randomized comparison of these two surgical methods.
  3. Hypothesis There is no difference in the cervical length and overall cervical angle between 1 month, 3 months, 6 months, and 12 months postoperatively between C3 laminectomy with C4-6 laminoplasty and C3-6 laminoplasty.
Read the detailed description

Surgery is performed under general anesthesia as before, followed by posterior cervical incision. In one group, the cervical spine of the C3 is removed using a drill and punch and C4-6 laminoplasty will be performed. In the other group, C3-6 laminoiplasty will be performed. Postoperative suturing and subject management are the same as existing patient care policies. Follow-up is performed at 1 month, 3 months, 6 months, 12 months, and 1 year after surgery at the outpatient clinic and x-ray is taken at each outpatient follow-up. The degree of the neck pain is measured using NDI and VAS for each outpatient f/u.

02

Conditions studied

  • Neck Pain

Browse trials for

03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 254 are open to participants now.

Browse Neck Pain studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients with cervical stenosis who should undergo cervical laminoplasty

Inclusion criteria

  • cervical stenosis

Exclusion criteria

Exclusion Criteria:

  • metastatic tumor
  • fracture
  • previous cervical spine surgery (posterior approach)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • C3 laminectomy

    laminectomy at C3 level and laminoplasty at C4-6 level

    Procedure: laminectomy at C3 level

  • C3 laminoplasty

    laminoplasty at C3-6 level

    Procedure: laminectomy at C3 level

Interventions

  • Procedurelaminectomy at C3 level

    laminectomy at C3 level

06

What researchers measure

Primary outcomes

  1. neck pain

    Numerical rating pain score on neck, 0\~10, 0 is no pain, 10 is maximum pain

    Time frame: 1 year

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06374680
Lead sponsor
Seoul National University Hospital
Responsible party
Chun Kee Chung (professor, Seoul National University Hospital) — Principal investigator
First posted
Apr 19, 2024
Start date
Mar 20, 2017
Primary completion
Dec 31, 2021 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Apr 22, 2024

Study contacts

Chun Kee Chung, MD, PhD
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion